Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serigne N Lo

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
The British Journal of Dermatology|December 20, 2023
Insights into the statistical quality of randomized clinical trial reports submitted to the British Journal of DermatologySerigne N Lo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Reply to M. Horiguchi et alSerigne N Lo, Shahneen Sandhu
The New England Journal of Medicine|August 24, 2022
Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. ReplyJeanne Tie, Serigne N Lo, Peter Gibbs
The British Journal of Dermatology|August 10, 2023
Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysisJuliet Smith, Anne E Cust, Serigne N Lo
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 16, 2021
Surgical excision margins in primary cutaneous melanoma: A systematic review and meta-analysisSarah Hanna, Serigne N Lo, Robyn Pm Saw
Annals of Surgical Oncology|November 11, 2018
ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous MelanomasJohn F Thompson, Richard A Scolyer, Serigne N Lo
Frontiers in Medicine|February 21, 2024
Commentary: Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillanceAlexander D G Anderson, Serigne N Lo, Pascale Guitera
Annals of Surgical Oncology|January 14, 2018
Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk TumorsSerigne N Lo, Richard A Scolyer, John F Thompson
European Journal of Cancer (Oxford, England : 1990)|November 30, 2025
Letter Re: Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma patients: A nationwide population-based studyAlexander Hr Varey, Serigne N Lo, John F Thompson
The British Journal of Dermatology|November 18, 2025
From significance to relevance: raising the bar for harm in dermatologyJoerg Albrecht, Jo Leonardi-Bee, Sonia Gran, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
The British Journal of Dermatology|December 20, 2023
Insights into the statistical quality of randomized clinical trial reports submitted to the British Journal of DermatologySerigne N Lo
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Reply to M. Horiguchi et alSerigne N Lo, Shahneen Sandhu
The New England Journal of Medicine|August 24, 2022
Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. ReplyJeanne Tie, Serigne N Lo, Peter Gibbs
The British Journal of Dermatology|August 10, 2023
Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysisJuliet Smith, Anne E Cust, Serigne N Lo
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 16, 2021
Surgical excision margins in primary cutaneous melanoma: A systematic review and meta-analysisSarah Hanna, Serigne N Lo, Robyn Pm Saw
Annals of Surgical Oncology|November 11, 2018
ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous MelanomasJohn F Thompson, Richard A Scolyer, Serigne N Lo
Frontiers in Medicine|February 21, 2024
Commentary: Real-world post-deployment performance of a novel machine learning-based digital health technology for skin lesion assessment and suggestions for post-market surveillanceAlexander D G Anderson, Serigne N Lo, Pascale Guitera
Annals of Surgical Oncology|January 14, 2018
Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk TumorsSerigne N Lo, Richard A Scolyer, John F Thompson
European Journal of Cancer (Oxford, England : 1990)|November 30, 2025
Letter Re: Critical evaluation of sentinel lymph node biopsy in pT1b and pT2a melanoma patients: A nationwide population-based studyAlexander Hr Varey, Serigne N Lo, John F Thompson
The British Journal of Dermatology|November 18, 2025
From significance to relevance: raising the bar for harm in dermatologyJoerg Albrecht, Jo Leonardi-Bee, Sonia Gran, et al.
Pageof 16